Usefulness of FDG-PET for Advanced Cervical Cancer (NCT00146458) | Clinical Trial Compass
UnknownPhase 3
Usefulness of FDG-PET for Advanced Cervical Cancer
Taiwan200 participantsStarted 2002-01
Plain-language summary
The objective of this study is to determinate whether the adding of FDG-PET is helpful in the treatment of advanced cervical cancer with concurrent chemoradiation.
Who can participate
Age range
0 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Newly diagnosed cervical cancer clinical stage FIGO I -IVA
* Histologically proven cervical carcinoma (including histologic types of squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma, lymphoepithelial-like carcinoma and malignant mixed mullerian tumor)
* Presence of at least one enlarged pelvic lymph node (\>=1.0 cm in its maximal dimension), or group of small pelvic nodes (size \<1 cm), and without suspicious para-aortic lymph node metastasis or any lesion outside the pelvis by conventional MRI or CT study
* Karnofsky performance scale \>=60
* Available for concurrent chemoradiation therapy of curative intent
Exclusion Criteria:
* Cervical tumor with histologic diagnosis of verrucous carcinoma or small cell carcinoma
* Other serious illness or medical condition which would interfere with extended field irradiation or chemotherapy
* Past or current history of malignancy, except for curatively treated non-melanoma skin cancer
* Patients not suitable to receive PET study either by technical or psychological reasons
* Patients who are judged to be noncompliant to treatment or not accessible for follow up
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The difference of disease-free-survival and overall-survival with/ without FDG-PET at two years after treatment